DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors

Immunology and Cell Biology

Volumn 75, Issue 4, 1997, Pages 382-388

  Ramsay, Alistair J ^a   Leong, Kah Hoo ^a   Ramshaw, Ian A ^a  

^a Biology and Environment   (Australia)

Author keywords

Consecutive immunization strategy; DNA vaccines; Virus infection

Indexed keywords

CYTOKINE; DNA VACCINE; VIRUS DNA; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL MODEL; CELLULAR IMMUNITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOPROPHYLAXIS; INFLUENZA; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; REVIEW; VIRUS INFECTION;

ANIMALIA; DNA VIRUSES; FOWLPOX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS;

EID: 9844239902     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.60     Document Type: Review

References (55)

1. Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-8.
2. Tang D-C, Devit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356: 152-4.
3. Williams RS, Johnston SA, Riedy M, Devit MJ, McElligot SG, Sanford JC. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc. Natl Acad. Sci. USA 1991; 88: 2726-30.
4. Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-9.
5. Montgomery DL, Shiver JW, Leander KR et al. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 1993; 9: 777-83.
6. Deck RR, DeWitt CM, Donnelly JJ, Liu MA, Ulmer JB. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine 1997; 15: 71-8.
7. Yankauckas MA, Morrow JE, Parker SE et al. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 1993; 12: 771-6.
8. Fu TM, Friedman A, Ulmer J, Liu MA, Donnelly JJ. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 1997; 71: 2715-21.
9. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. USA 1993; 90: 11 478-82.
10. Justewicz DM, Webster RG. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Virology 1996; 224: 10-17.
11. Webster RG, Fynan EF, Santoro JC, Robinson HL. Protection of ferrets against influenza challenge with a DNA vaccine to the hemagglutinin. Vaccine 1994; 12: 1495-8.
12. Kodihalli S, Haynes JR, Robinson HL, Webster R.G. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J. Virol. 1997; 71: 3391-6.
13. Donnelly JJ, Friedman A, Martinez D et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against drift in influenza virus. Nature Med. 1995; 1: 583-7.
14. Wang B, Ugen KE, Srikantan V et al. Gene inoculation generates immune responses against immunodeficiency virus type I. Proc. Natl Acad. Sci. USA 1993; 90: 4146-60.
15. Haynes JR, Fuller DH, Eisenbraun MD, Ford MJ, Pertmer DM. A cell particle-mediated DNA immunization elicits humoral, cytotoxic and protective responses. AIDS Res. Hum. Retroviruses 1995; 11: 933-43.
16. Lu S, Santoro JC, Fuller DH, Haynes JR, Robinson HL. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 1995; 209: 147-54.
17. Asakura Y, Hamajima K, Fukushima J, Mohri H, Okubo T, Okuda K. Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine. Am. J. Hematol. 1996; 53: 116-17.
18. Yasutomi Y, Robinson HL, Lu S et al. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 1996; 70: 678-81.
19. Kim JJ, Ayyavoo V, Bagarazzi ML et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 1997; 158: 816-26.
20. Ramshaw I, Ruby J, Ramsay A, Ada G, Karupiah G. Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo. Immunol. Rev. 1992; 127: 157-82.
21. Ramsay AJ, Husband AJ, Ramshaw IA et al. The role of interleukin-6 in mucosal antibody responses in vivo. Science 1994; 264: 561-3.
22. Lu S, Arthos J, Montefiori DC et al. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 1996; 70: 3978-91.
23. Boyer DJ, Ugen KE, Wang B et al. Protection of chimpanzees from high dose heterologous HIV-1 challenge by DNA vaccination. Nature Med. 1997; 3: 526-32.
24. Cox GJM, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 1993; 67: 5664-7.
25. Bourne N, Stanberry LR, Bernstein DI, Lew D. DNA immunization against experimental genital herpes simplex virus infection. J. Inf. Dis. 1996; 173: 800-7.
26. Kriesel JD, Spruance SL, Daynes RA, Araneo BA. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J. Infect. Dis. 1996; 173: 536-41.
27. McClements WL, Armstrong ME, Keys RD, Liu MD. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl Acad. Sci. USA 1996; 93: 11 414-20.
28. Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 1997; 71: 3138-45.
29. Donnelly JJ, Martinez D, Jansen KU, Ellis RW, Montgomery DL, Liu MA. Protection against papillomavirus with a polynucleotide vaccine. J. Infect. Dis. 1996; 173: 314-20.
30. Davis HL, Michel ML, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 1993; 2: 1847-51.
31. Davis HL, McCluskie ML, Gerin JL, Purcell RH. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl Acad. Sci. USA 1996; 93: 7213-18.
32. Chow YH, Huang WL, Chi WK, Chu YD, Tao MH. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 1997; 71: 169-78.
33. Schirmbeck R, Bohm W, Ando K, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 1995; 69: 5929-34.
34. Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RE, Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 1995; 69: 5859-63.
35. Major ME, Vitvitski L, Mink MA et al. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 1995; 69: 5798-805.
36. Geissler M, Gesien A, Tokushige K, Wands JR. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 1997; 158: 1231-7.
37. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994; 199: 132-40.
38. Wang Y, Xiang Z, Pasquini S, Ertl HC. Immune response to neonatal genetic immunization. Virology 1997; 228: 278-84.
39. Pedros Martins L, Lau LL, Asano MS, Ahmed R. DNA vaccination against persistent viral infection. J. Virol. 1995; 69: 2574-82.
40. Yokoyama M, Zhang J, Whitton JL. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 1995; 69: 2684-8.
41. Osterrieder N, Wagner R, Brandmuller C, Schmidt P, Wolf H, Kaaden OR. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 1995; 208: 500-10.
42. Sakaguchi M, Nakamura H, Sonoda K, Hamada F, Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine 1996; 14: 747-52.
43. Herrmann JE., Chen SC, Fynan EF et al. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 1996; 174 (Suppl. 1): S93-7.
44. Phillpotts RJ, Venugopal K, Brooks T. Immunization with DNA: polynucleotides protect mice against lethal challenge with St. Louis encephalitis virus. Arch. Virol. 1996; 141: 743-9.
45. Armas JC, Morello CS, Cranmer LD, Spector DH. DNA immunization confers protection against murine cytomegalo-virus infection. J. Virol. 1996; 70: 7921-8.
46. Harpin S, Talbot B, Mbikay M, Elazhary Y. Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microbiol. Lett. 1997; 146: 229-34.
47. Leong KH, Ramsay AJ, Boyle DB, Ramshaw IA. Selective induction of immune responses by cytokines co-expressed in recombinant fowlpox virus. J. Virol. 1994; 68: 8125-30.
48. Doherty PC, Allan W, Boyle DB, Coupar BEH, Andrew ME. Recombinant vaccinia viruses and the development of immunization strategies using influenza virus. J. Infect. Dis. 1989; 159: 1119-22.
49. Blanden RV. T cells responses to viral and bacterial infection. Transplant. Rev. 1974; 19: 56-88.
50. + T cells is dependent on interferon-γ. Lymphokine Cytokine Res. 1991; 10: 353-8.
51. Ramsay AJ, Ruby J, Ramshaw IA. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 1993; 14: 155-7.
52. Huang S, Hendriks W, Althage A et al. Immune response in mice that lack the interferon-γ receptor. Science 1993; 259: 1742-5.
53. Muller U, Steinhoff U, Reis LFL et al. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918-21.
54. Sato Y, Roman M, Tighe H et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunisation. Science 1996; 273: 352-4.
55. Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunisation. J. Immunol. 1997; 158: 2278-84.